<pages>
<page id="1" bbox="0.000,0.000,720.000,540.000" rotate="0">
<title id="0" bbox="238.540,294.542,481.446,386.102" size="44.04" unique_id="0">Tipranavir  
NDA 21-814 <textline bbox="254.020,342.062,478.316,386.102" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">Tipranavir  </textline>
<textline bbox="238.540,294.542,481.446,338.582" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">NDA 21-814 </textline>
</title>
<normal_text id="1" bbox="196.180,109.108,572.428,173.330" size="25.98" unique_id="1">Antiviral Drugs Advisory Committee 
May 19, 2005 <textline bbox="196.180,149.330,572.428,173.330" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">Antiviral Drugs Advisory Committee </textline>
<textline bbox="290.020,109.108,460.017,137.068" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">May 19, 2005 </textline>
</normal_text>
<picture name="Image21" bbox="24.000,74.640,174.000,222.000" src="Image21.286x281.bmp" width="150" height="147" unique_id="2">
</picture>
</page>
<page id="2" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[143.47, 447.662, 588.758, 491.702]">
<title id="0" bbox="143.470,447.662,588.758,491.702" size="44.04" unique_id="0">HIV Drug Resistance  <textline bbox="143.470,447.662,588.758,491.702" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">HIV Drug Resistance  </textline>
</title>
<slide_number id="6" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="6">2 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">2 </textline>
</slide_number>
<enlisting bbox="55.2,172.258,669.569,392.631" unique_id="['1', '  2', '  4', ' 3', '5']">&#8226; Different patient populations &#8211; Na&#239;ve subjects harboring resistant virus 
&#8211; Limited or Intermediate prior treatment with  &#8211; Extensive prior treatment with resistance  <normal_text id="1" bbox="55.200,360.567,479.497,392.631" size="32.064" unique_id="1">&#8226; Different patient populations <textline bbox="55.200,360.567,479.497,392.631" font="ArialMT" ncolour="1" size="32.064" colourspace="Pattern">&#8226; Different patient populations </textline>
</normal_text>
<normal_text id="2" bbox="91.224,279.798,655.952,348.078" size="27.96" unique_id="2">&#8211; Na&#239;ve subjects harboring resistant virus 
&#8211; Limited or Intermediate prior treatment with  <textline bbox="91.224,320.118,604.478,348.078" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Na&#239;ve subjects harboring resistant virus </textline>
<textline bbox="91.224,279.798,655.952,307.758" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Limited or Intermediate prior treatment with  </textline>
</normal_text>
<normal_text id="4" bbox="91.224,205.858,669.569,233.818" size="27.96" unique_id="4">&#8211; Extensive prior treatment with resistance  <textline bbox="91.224,205.858,669.569,233.818">&#8211; Extensive prior treatment with resistance  <text font="ArialMT" bbox="91.224,205.858,106.770,233.818" colourspace="Pattern" ncolour="1" size="27.960">&#8211;</text>
<text font="Arial-BoldMT" bbox="113.780,205.858,132.429,233.818" colourspace="Pattern" ncolour="1" size="27.960">E</text>
<text font="Arial-BoldMT" bbox="132.429,205.858,147.975,233.818" colourspace="Pattern" ncolour="1" size="27.960">x</text>
<text font="Arial-BoldMT" bbox="147.975,205.858,157.286,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="157.286,205.858,172.832,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="172.915,205.858,189.999,233.818" colourspace="Pattern" ncolour="1" size="27.960">n</text>
<text font="Arial-BoldMT" bbox="189.999,205.858,205.545,233.818" colourspace="Pattern" ncolour="1" size="27.960">s</text>
<text font="Arial-BoldMT" bbox="205.545,205.858,213.318,233.818" colourspace="Pattern" ncolour="1" size="27.960">i</text>
<text font="Arial-BoldMT" bbox="213.318,205.858,228.863,233.818" colourspace="Pattern" ncolour="1" size="27.960">v</text>
<text font="Arial-BoldMT" bbox="228.919,205.858,244.465,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="244.465,205.858,252.238,233.818" colourspace="Pattern" ncolour="1" size="27.960"> </text>
<text font="Arial-BoldMT" bbox="252.406,205.858,269.489,233.818" colourspace="Pattern" ncolour="1" size="27.960">p</text>
<text font="Arial-BoldMT" bbox="269.489,205.858,280.366,233.818" colourspace="Pattern" ncolour="1" size="27.960">r</text>
<text font="Arial-BoldMT" bbox="280.366,205.858,288.139,233.818" colourspace="Pattern" ncolour="1" size="27.960">i</text>
<text font="Arial-BoldMT" bbox="288.139,205.858,305.222,233.818" colourspace="Pattern" ncolour="1" size="27.960">o</text>
<text font="Arial-BoldMT" bbox="305.222,205.858,316.099,233.818" colourspace="Pattern" ncolour="1" size="27.960">r</text>
<text font="Arial-BoldMT" bbox="316.099,205.858,323.871,233.818" colourspace="Pattern" ncolour="1" size="27.960"> </text>
<text font="Arial-BoldMT" bbox="323.871,205.858,333.182,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="333.266,205.858,344.142,233.818" colourspace="Pattern" ncolour="1" size="27.960">r</text>
<text font="Arial-BoldMT" bbox="344.142,205.858,359.688,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="359.744,205.858,375.290,233.818" colourspace="Pattern" ncolour="1" size="27.960">a</text>
<text font="Arial-BoldMT" bbox="375.290,205.858,384.601,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="384.684,205.858,409.541,233.818" colourspace="Pattern" ncolour="1" size="27.960">m</text>
<text font="Arial-BoldMT" bbox="409.541,205.858,425.087,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="425.087,205.858,442.170,233.818" colourspace="Pattern" ncolour="1" size="27.960">n</text>
<text font="Arial-BoldMT" bbox="442.170,205.858,451.481,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="451.481,205.858,459.254,233.818" colourspace="Pattern" ncolour="1" size="27.960"> </text>
<text font="Arial-BoldMT" bbox="459.422,205.858,481.174,233.818" colourspace="Pattern" ncolour="1" size="27.960">w</text>
<text font="Arial-BoldMT" bbox="481.174,205.858,488.947,233.818" colourspace="Pattern" ncolour="1" size="27.960">i</text>
<text font="Arial-BoldMT" bbox="488.947,205.858,498.258,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="498.258,205.858,515.342,233.818" colourspace="Pattern" ncolour="1" size="27.960">h</text>
<text font="Arial-BoldMT" bbox="515.342,205.858,523.114,233.818" colourspace="Pattern" ncolour="1" size="27.960"> </text>
<text font="Arial-BoldMT" bbox="523.226,205.858,534.103,233.818" colourspace="Pattern" ncolour="1" size="27.960">r</text>
<text font="Arial-BoldMT" bbox="534.103,205.858,549.648,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="549.704,205.858,565.250,233.818" colourspace="Pattern" ncolour="1" size="27.960">s</text>
<text font="Arial-BoldMT" bbox="565.250,205.858,573.023,233.818" colourspace="Pattern" ncolour="1" size="27.960">i</text>
<text font="Arial-BoldMT" bbox="573.023,205.858,588.569,233.818" colourspace="Pattern" ncolour="1" size="27.960">s</text>
<text font="Arial-BoldMT" bbox="588.681,205.858,597.991,233.818" colourspace="Pattern" ncolour="1" size="27.960">t</text>
<text font="Arial-BoldMT" bbox="597.991,205.858,613.537,233.818" colourspace="Pattern" ncolour="1" size="27.960">a</text>
<text font="Arial-BoldMT" bbox="613.621,205.858,630.704,233.818" colourspace="Pattern" ncolour="1" size="27.960">n</text>
<text font="Arial-BoldMT" bbox="630.704,205.858,646.250,233.818" colourspace="Pattern" ncolour="1" size="27.960">c</text>
<text font="Arial-BoldMT" bbox="646.250,205.858,661.796,233.818" colourspace="Pattern" ncolour="1" size="27.960">e</text>
<text font="Arial-BoldMT" bbox="661.796,205.858,669.569,233.818" colourspace="Pattern" ncolour="1" size="27.960"> </text>
</textline>
</normal_text>
<normal_text id="3" bbox="113.780,246.193,241.583,274.177" size="27.984" unique_id="3">resistance <textline bbox="113.780,246.193,241.583,274.177" font="ArialMT" ncolour="1" size="27.984" colourspace="Pattern">resistance </textline>
</normal_text>
<normal_text id="5" bbox="113.780,172.258,511.902,200.218" size="27.96" unique_id="5">with limited treatment options <textline bbox="113.780,172.258,511.902,200.218" font="Arial-BoldMT" ncolour="1" size="27.960" colourspace="Pattern">with limited treatment options </textline>
</normal_text>
</enlisting></page>
<page id="3" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[87.79133333333334, 449.2726666666667, 636.1406666666667, 490.5926666666667]">
<title id="0" bbox="59.952,450.078,659.832,490.038" size="39.96" unique_id="0">HIV Drug Resistance in the U.S. <textline bbox="59.952,450.078,659.832,490.038" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="39.960" colourspace="Pattern">HIV Drug Resistance in the U.S. </textline>
</title>
<slide_number id="3" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="3">3 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">3 </textline>
</slide_number>
<enlisting bbox="55.2,82.096,640.804,392.631" unique_id="['1', '2']">&#8226; Treatment-experienced subject cohort   
with VL &gt; 500 copies/ml from HIV Cost  
and Service Utilization Study (Richman, et  
al, AIDS, 2004)  &#8226; Overall resistance was 76% 
&#8226; 2-class resistance = 48% 
&#8226; 3-class resistance = 13% <normal_text id="1" bbox="55.200,254.705,640.804,392.631" size="30.042" unique_id="1">&#8226; Treatment-experienced subject cohort   
with VL &gt; 500 copies/ml from HIV Cost  
and Service Utilization Study (Richman, et  
al, AIDS, 2004)  <textline bbox="55.200,360.567,636.703,392.631" font="ArialMT" ncolour="1" size="32.064" colourspace="Pattern">&#8226; Treatment-experienced subject cohort   </textline>
<textline bbox="82.224,322.142,638.246,354.182" font="ArialMT" ncolour="1" size="32.040" colourspace="Pattern">with VL &gt; 500 copies/ml from HIV Cost  </textline>
<textline bbox="82.224,283.742,640.804,315.782">and Service Utilization Study (Richman, et  <text font="ArialMT" bbox="82.224,283.742,100.038,315.782" colourspace="Pattern" ncolour="1" size="32.040">a</text>
<text font="ArialMT" bbox="100.038,283.742,117.852,315.782" colourspace="Pattern" ncolour="1" size="32.040">n</text>
<text font="ArialMT" bbox="117.756,283.742,135.571,315.782" colourspace="Pattern" ncolour="1" size="32.040">d</text>
<text font="ArialMT" bbox="135.571,283.742,144.478,315.782" colourspace="Pattern" ncolour="1" size="32.040"> </text>
<text font="ArialMT" bbox="144.478,283.742,165.848,315.782" colourspace="Pattern" ncolour="1" size="32.040">S</text>
<text font="ArialMT" bbox="165.848,283.742,183.663,315.782" colourspace="Pattern" ncolour="1" size="32.040">e</text>
<text font="ArialMT" bbox="183.502,283.742,194.172,315.782" colourspace="Pattern" ncolour="1" size="32.040">r</text>
<text font="ArialMT" bbox="194.172,283.742,210.192,315.782" colourspace="Pattern" ncolour="1" size="32.040">v</text>
<text font="ArialMT" bbox="210.192,283.742,217.305,315.782" colourspace="Pattern" ncolour="1" size="32.040">i</text>
<text font="ArialMT" bbox="217.305,283.742,233.325,315.782" colourspace="Pattern" ncolour="1" size="32.040">c</text>
<text font="ArialMT" bbox="233.389,283.742,251.203,315.782" colourspace="Pattern" ncolour="1" size="32.040">e</text>
<text font="ArialMT" bbox="251.203,283.742,260.110,315.782" colourspace="Pattern" ncolour="1" size="32.040"> </text>
<text font="ArialMT" bbox="259.790,283.742,282.923,315.782" colourspace="Pattern" ncolour="1" size="32.040">U</text>
<text font="ArialMT" bbox="282.923,283.742,291.830,315.782" colourspace="Pattern" ncolour="1" size="32.040">t</text>
<text font="ArialMT" bbox="291.830,283.742,298.943,315.782" colourspace="Pattern" ncolour="1" size="32.040">i</text>
<text font="ArialMT" bbox="298.943,283.742,306.055,315.782" colourspace="Pattern" ncolour="1" size="32.040">l</text>
<text font="ArialMT" bbox="306.055,283.742,313.168,315.782" colourspace="Pattern" ncolour="1" size="32.040">i</text>
<text font="ArialMT" bbox="313.072,283.742,329.092,315.782" colourspace="Pattern" ncolour="1" size="32.040">z</text>
<text font="ArialMT" bbox="329.092,283.742,346.906,315.782" colourspace="Pattern" ncolour="1" size="32.040">a</text>
<text font="ArialMT" bbox="346.906,283.742,355.814,315.782" colourspace="Pattern" ncolour="1" size="32.040">t</text>
<text font="ArialMT" bbox="355.814,283.742,362.926,315.782" colourspace="Pattern" ncolour="1" size="32.040">i</text>
<text font="ArialMT" bbox="362.926,283.742,380.741,315.782" colourspace="Pattern" ncolour="1" size="32.040">o</text>
<text font="ArialMT" bbox="380.645,283.742,398.459,315.782" colourspace="Pattern" ncolour="1" size="32.040">n</text>
<text font="ArialMT" bbox="398.459,283.742,407.366,315.782" colourspace="Pattern" ncolour="1" size="32.040"> </text>
<text font="ArialMT" bbox="407.366,283.742,428.737,315.782" colourspace="Pattern" ncolour="1" size="32.040">S</text>
<text font="ArialMT" bbox="428.737,283.742,437.644,315.782" colourspace="Pattern" ncolour="1" size="32.040">t</text>
<text font="ArialMT" bbox="437.516,283.742,455.330,315.782" colourspace="Pattern" ncolour="1" size="32.040">u</text>
<text font="ArialMT" bbox="455.330,283.742,473.144,315.782" colourspace="Pattern" ncolour="1" size="32.040">d</text>
<text font="ArialMT" bbox="473.048,283.742,489.068,315.782" colourspace="Pattern" ncolour="1" size="32.040">y</text>
<text font="ArialMT" bbox="489.068,283.742,497.975,315.782" colourspace="Pattern" ncolour="1" size="32.040"> </text>
<text font="ArialMT" bbox="498.100,285.430,506.092,309.430" colourspace="Pattern" ncolour="1" size="24.000">(</text>
<text font="ArialMT" bbox="506.092,285.430,523.420,309.430" colourspace="Pattern" ncolour="1" size="24.000">R</text>
<text font="ArialMT" bbox="523.420,285.430,528.748,309.430" colourspace="Pattern" ncolour="1" size="24.000">i</text>
<text font="ArialMT" bbox="528.748,285.430,540.748,309.430" colourspace="Pattern" ncolour="1" size="24.000">c</text>
<text font="ArialMT" bbox="540.748,285.430,554.092,309.430" colourspace="Pattern" ncolour="1" size="24.000">h</text>
<text font="ArialMT" bbox="554.020,285.430,574.012,309.430" colourspace="Pattern" ncolour="1" size="24.000">m</text>
<text font="ArialMT" bbox="574.012,285.430,587.356,309.430" colourspace="Pattern" ncolour="1" size="24.000">a</text>
<text font="ArialMT" bbox="587.356,285.430,600.700,309.430" colourspace="Pattern" ncolour="1" size="24.000">n</text>
<text font="ArialMT" bbox="600.700,285.430,607.372,309.430" colourspace="Pattern" ncolour="1" size="24.000">,</text>
<text font="ArialMT" bbox="607.372,285.430,614.044,309.430" colourspace="Pattern" ncolour="1" size="24.000"> </text>
<text font="ArialMT" bbox="614.116,285.430,627.460,309.430" colourspace="Pattern" ncolour="1" size="24.000">e</text>
<text font="ArialMT" bbox="627.460,285.430,634.132,309.430" colourspace="Pattern" ncolour="1" size="24.000">t</text>
<text font="ArialMT" bbox="634.132,285.430,640.804,309.430" colourspace="Pattern" ncolour="1" size="24.000"> </text>
</textline>
<textline bbox="82.224,254.705,250.128,278.729" font="ArialMT" ncolour="1" size="24.024" colourspace="Pattern">al, AIDS, 2004)  </textline>
</normal_text>
<normal_text id="2" bbox="55.200,82.096,476.572,206.322" size="32.048" unique_id="2">&#8226; Overall resistance was 76% 
&#8226; 2-class resistance = 48% 
&#8226; 3-class resistance = 13% <textline bbox="55.200,174.282,476.572,206.322" font="ArialMT" ncolour="1" size="32.040" colourspace="Pattern">&#8226; Overall resistance was 76% </textline>
<textline bbox="55.200,128.197,438.546,160.261" font="ArialMT" ncolour="1" size="32.064" colourspace="Pattern">&#8226; 2-class resistance = 48% </textline>
<textline bbox="55.200,82.096,438.429,114.136" font="ArialMT" ncolour="1" size="32.040" colourspace="Pattern">&#8226; 3-class resistance = 13% </textline>
</normal_text>
</enlisting></page>
<page id="4" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[53.69966666666667, 468.8298333333334, 674.3418333333333, 505.5218333333334]">
<title id="0" bbox="19.608,488.387,712.543,520.451" size="32.064" unique_id="0">Prevalence of Estimated HIV Drug Resistance <textline bbox="19.608,488.387,712.543,520.451" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="32.064" colourspace="Pattern">Prevalence of Estimated HIV Drug Resistance </textline>
</title>
<normal_text id="1" bbox="169.220,387.950,205.142,405.950" size="18.0" unique_id="1">76% <textline bbox="169.220,387.950,205.142,405.950" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">76% </textline>
</normal_text>
<normal_text id="2" bbox="259.250,369.950,295.172,387.950" size="18.0" unique_id="2">71% <textline bbox="259.250,369.950,295.172,387.950" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">71% </textline>
</normal_text>
<normal_text id="3" bbox="8.040,367.996,32.040,374.668" size="6.672" unique_id="3">  <textline bbox="8.040,367.996,32.040,374.668" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">  </textline>
</normal_text>
<normal_text id="4" bbox="8.040,270.700,32.040,367.996" size="12.956571428571428" unique_id="4">s 
t 
c 
e 
b 
u 
s <textline bbox="8.040,354.652,32.040,367.996" font="Arial-BoldMT" ncolour="1" size="13.344" colourspace="Pattern">s </textline>
<textline bbox="8.040,346.660,32.040,354.652" font="Arial-BoldMT" ncolour="1" size="7.992" colourspace="Pattern">t </textline>
<textline bbox="8.040,333.316,32.040,346.660" font="Arial-BoldMT" ncolour="1" size="13.344" colourspace="Pattern">c </textline>
<textline bbox="8.040,319.972,32.040,333.316" font="Arial-BoldMT" ncolour="1" size="13.344" colourspace="Pattern">e </textline>
<textline bbox="8.040,298.636,32.040,313.300" font="Arial-BoldMT" ncolour="1" size="14.664" colourspace="Pattern">b </textline>
<textline bbox="8.040,284.044,32.040,298.708" font="Arial-BoldMT" ncolour="1" size="14.664" colourspace="Pattern">u </textline>
<textline bbox="8.040,270.700,32.040,284.044" font="Arial-BoldMT" ncolour="1" size="13.344" colourspace="Pattern">s </textline>
</normal_text>
<normal_text id="5" bbox="8.040,313.300,32.040,319.972" size="6.672" unique_id="5">j <textline bbox="8.040,313.300,32.040,319.972" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">j </textline>
</normal_text>
<normal_text id="6" bbox="8.040,257.356,32.040,270.700" size="6.672" unique_id="6">  
. <textline bbox="8.040,264.028,32.040,270.700" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">  </textline>
<textline bbox="8.040,257.356,32.040,264.028" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">. </textline>
</normal_text>
<normal_text id="7" bbox="8.040,234.676,32.040,241.348" size="6.672" unique_id="7">. <textline bbox="8.040,234.676,32.040,241.348" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">. </textline>
</normal_text>
<normal_text id="8" bbox="8.040,217.444,32.040,257.356" size="16.668" unique_id="8">S 
U <textline bbox="8.040,241.348,32.040,257.356" font="Arial-BoldMT" ncolour="1" size="16.008" colourspace="Pattern">S </textline>
<textline bbox="8.040,217.444,32.040,234.772" font="Arial-BoldMT" ncolour="1" size="17.328" colourspace="Pattern">U </textline>
</normal_text>
<enlisting id="9" bbox="8.04,147.58,60.845,217.444" size="12.666" unique_id="['9', '  10', ' 15', '14']">  
f 
o 
% <textline bbox="8.040,210.772,32.040,217.444" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">  </textline>
<textline bbox="8.040,202.780,32.040,210.772" font="Arial-BoldMT" ncolour="1" size="7.992" colourspace="Pattern">f </textline>
<textline bbox="8.040,188.116,32.040,202.780" font="Arial-BoldMT" ncolour="1" size="14.664" colourspace="Pattern">o </textline>
<textline bbox="8.040,160.180,32.040,181.516" font="Arial-BoldMT" ncolour="1" size="21.336" colourspace="Pattern">% </textline>
<normal_text id="10" bbox="8.040,181.060,32.040,187.732" size="6.672" unique_id="10">  <textline bbox="8.040,181.060,32.040,187.732" font="Arial-BoldMT" ncolour="1" size="6.672" colourspace="Pattern">  </textline>
</normal_text>
<normal_text id="15" bbox="36.821,147.580,60.845,166.271" size="18.691" unique_id="15">w <textline bbox="36.821,147.580,60.845,166.271" font="Arial-BoldMT" ncolour="1" size="18.691" colourspace="Pattern">w </textline>
</normal_text>
<normal_text id="14" bbox="36.821,195.796,60.845,202.475" size="6.679" unique_id="14">  <textline bbox="36.821,195.796,60.845,202.475" font="Arial-BoldMT" ncolour="1" size="6.679" colourspace="Pattern">  </textline>
</normal_text>
</enlisting>
<normal_text id="11" bbox="36.821,304.673,60.845,380.685" size="12.6845" unique_id="11">e 
c 
n 
a 
t 
s <textline bbox="36.821,367.328,60.845,380.685" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">e </textline>
<textline bbox="36.821,353.970,60.845,367.328" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">c </textline>
<textline bbox="36.821,339.388,60.845,354.066" font="Arial-BoldMT" ncolour="1" size="14.679" colourspace="Pattern">n </textline>
<textline bbox="36.821,326.030,60.845,339.388" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">a </textline>
<textline bbox="36.821,318.030,60.845,326.030" font="Arial-BoldMT" ncolour="1" size="8.000" colourspace="Pattern">t </textline>
<textline bbox="36.821,304.673,60.845,318.030" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">s </textline>
</normal_text>
<normal_text id="12" bbox="36.821,297.994,60.845,304.673" size="6.679" unique_id="12">i <textline bbox="36.821,297.994,60.845,304.673" font="Arial-BoldMT" ncolour="1" size="6.679" colourspace="Pattern">i </textline>
</normal_text>
<normal_text id="13" bbox="36.821,166.511,60.845,297.994" size="11.40709090909091" unique_id="13">s 
e 
r 
  
g 
u 
r 
d 
h 
t 
i <textline bbox="36.821,284.637,60.845,297.994" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">s </textline>
<textline bbox="36.821,271.280,60.845,284.637" font="Arial-BoldMT" ncolour="1" size="13.357" colourspace="Pattern">e </textline>
<textline bbox="36.821,261.934,60.845,271.280" font="Arial-BoldMT" ncolour="1" size="9.345" colourspace="Pattern">r </textline>
<textline bbox="36.821,255.328,60.845,262.006" font="Arial-BoldMT" ncolour="1" size="6.679" colourspace="Pattern">  </textline>
<textline bbox="36.821,240.745,60.845,255.424" font="Arial-BoldMT" ncolour="1" size="14.679" colourspace="Pattern">g </textline>
<textline bbox="36.821,226.066,60.845,240.745" font="Arial-BoldMT" ncolour="1" size="14.679" colourspace="Pattern">u </textline>
<textline bbox="36.821,216.721,60.845,226.066" font="Arial-BoldMT" ncolour="1" size="9.345" colourspace="Pattern">r </textline>
<textline bbox="36.821,202.042,60.845,216.721" font="Arial-BoldMT" ncolour="1" size="14.679" colourspace="Pattern">d </textline>
<textline bbox="36.821,181.118,60.845,195.796" font="Arial-BoldMT" ncolour="1" size="14.679" colourspace="Pattern">h </textline>
<textline bbox="36.821,173.118,60.845,181.118" font="Arial-BoldMT" ncolour="1" size="8.000" colourspace="Pattern">t </textline>
<textline bbox="36.821,166.511,60.845,173.190" font="Arial-BoldMT" ncolour="1" size="6.679" colourspace="Pattern">i </textline>
</normal_text>
<normal_text id="16" bbox="517.300,287.050,553.222,305.050" size="18.0" unique_id="16">48% <textline bbox="517.300,287.050,553.222,305.050" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">48% </textline>
</normal_text>
<normal_text id="17" bbox="349.270,261.920,385.192,279.920" size="18.0" unique_id="17">41% <textline bbox="349.270,261.920,385.192,279.920" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">41% </textline>
</normal_text>
<normal_text id="18" bbox="433.270,207.900,469.192,225.900" size="18.0" unique_id="18">25% <textline bbox="433.270,207.900,469.192,225.900" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">25% </textline>
</normal_text>
<normal_text id="19" bbox="607.320,167.030,643.242,185.030" size="18.0" unique_id="19">13% <textline bbox="607.320,167.030,643.242,185.030" font="Arial-BoldMT" ncolour="0" size="18.000" colourspace="Pattern">13% </textline>
</normal_text>
<footer id="20" bbox="7.200,4.999,260.077,23.023" size="18.024" unique_id="20">Richman, et el. AIDS. July 2004 <textline bbox="7.200,4.999,260.077,23.023" font="ArialMT" ncolour="1" size="18.024" colourspace="Pattern">Richman, et el. AIDS. July 2004 </textline>
</footer>
<normal_text id="21" bbox="231.580,39.864,518.380,63.864" size="24.0" unique_id="21">Drug resistance detected <textline bbox="231.580,39.864,518.380,63.864" font="Arial-BoldMT" ncolour="1" size="24.000" colourspace="Pattern">Drug resistance detected </textline>
</normal_text>
<slide_number id="22" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="22">4 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">4 </textline>
</slide_number>
</page>
<page id="5" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[50.191, 453.59790000000004, 678.8531, 507.29310000000004]">
<title id="0" bbox="44.928,430.750,685.620,509.950" size="36.0" unique_id="0">Current State of Therapy for Patients  
with Limited Treatment Options <textline bbox="44.928,473.950,685.620,509.950" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="36.000" colourspace="Pattern">Current State of Therapy for Patients  </textline>
<textline bbox="91.032,430.750,628.944,466.750" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="36.000" colourspace="Pattern">with Limited Treatment Options </textline>
</title>
<slide_number id="5" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="5">5 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">5 </textline>
</slide_number>
<enlisting bbox="55.2,154.018,545.147,392.631" unique_id="['1', ' 2', ' 3', '4']">&#8226; Enfuvirtide(T-20) &#8211; Traditional approval 2004 
&#8226; Drugs in antiviral pipeline 
&#8226; Tipranavir &#8211; 2 key studies in a highly treatment  <normal_text id="1" bbox="55.200,360.567,318.647,392.631" size="32.064" unique_id="1">&#8226; Enfuvirtide(T-20) <textline bbox="55.200,360.567,318.647,392.631" font="ArialMT" ncolour="1" size="32.064" colourspace="Pattern">&#8226; Enfuvirtide(T-20) </textline>
</normal_text>
<normal_text id="2" bbox="55.200,228.042,439.214,348.078" size="30.679999999999996" unique_id="2">&#8211; Traditional approval 2004 
&#8226; Drugs in antiviral pipeline 
&#8226; Tipranavir <textline bbox="91.224,320.118,429.141,348.078" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Traditional approval 2004 </textline>
<textline bbox="55.200,274.142,439.214,306.182" font="ArialMT" ncolour="1" size="32.040" colourspace="Pattern">&#8226; Drugs in antiviral pipeline </textline>
<textline bbox="55.200,228.042,223.200,260.082" font="ArialMT" ncolour="1" size="32.040" colourspace="Pattern">&#8226; Tipranavir </textline>
</normal_text>
<normal_text id="3" bbox="91.224,187.618,545.147,215.578" size="27.96" unique_id="3">&#8211; 2 key studies in a highly treatment  <textline bbox="91.224,187.618,545.147,215.578" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; 2 key studies in a highly treatment  </textline>
</normal_text>
<normal_text id="4" bbox="113.780,154.018,403.725,181.978" size="27.96" unique_id="4">experienced population <textline bbox="113.780,154.018,403.725,181.978" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">experienced population </textline>
</normal_text>
</enlisting></page>
<page id="6" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[124.09400000000001, 437.8292666666667, 611.9924, 488.3060666666667]">
<title id="0" bbox="271.900,406.292,478.271,450.332" size="44.04" unique_id="0">Tipranavir  <textline bbox="271.900,406.292,478.271,450.332" font="ArialMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">Tipranavir  </textline>
</title>
<slide_number id="1" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="1">6 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">6 </textline>
</slide_number>
<picture name="Image57" bbox="84.000,59.969,636.000,317.999" src="Image57.1536x718.bmp" width="552" height="258" unique_id="2">
</picture>
</page>
<page id="7" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[117.49285714285713, 440.63861904761904, 613.9785714285714, 489.27633333333335]">
<title id="0" bbox="100.990,447.662,618.944,491.702" size="44.04" unique_id="0">Tipranavir/r: Trial Design <textline bbox="100.990,447.662,618.944,491.702" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">Tipranavir/r: Trial Design </textline>
</title>
<slide_number id="9" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="9">7 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">7 </textline>
</slide_number>
<enlisting bbox="55.2,117.372,622.412,393.247" unique_id="['1', '  2', '  4', '  7', '  8', ' 5', '3', ' 6']">&#8226; Resist 1 and Resist 2 &#8211; Open label &#8211; Amended protocol allowed patients with PI  &#8211; Escape clause @ week 8 to allow subjects with  VF to receive TPV in 1182.17 
&#8226; Loss of control arm @ week 8 &#8226; TPV/r + OBR vs CPI/r + OBR &#8226; Analyzed as superiority trials <normal_text bbox="55.2,117.372,622.412,393.247" unique_id="['1', ' 2', ' 4', ' 7', ' 8', '5']">&#8226; Resist 1 and Resist 2 &#8211; Open label &#8211; Amended protocol allowed patients with PI  &#8211; Escape clause @ week 8 to allow subjects with  VF to receive TPV in 1182.17 
&#8226; Loss of control arm @ week 8 <normal_text id="1" bbox="55.200,365.263,346.981,393.247" size="27.984" unique_id="1">&#8226; Resist 1 and Resist 2 <textline bbox="55.200,365.263,346.981,393.247" font="ArialMT" ncolour="1" size="27.984" colourspace="Pattern">&#8226; Resist 1 and Resist 2 </textline>
</normal_text>
<normal_text id="2" bbox="91.224,330.550,229.748,354.550" size="24.0" unique_id="2">&#8211; Open label <textline bbox="91.224,330.550,229.748,354.550" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8211; Open label </textline>
</normal_text>
<normal_text id="4" bbox="91.224,267.190,572.972,291.190" size="24.0" unique_id="4">&#8211; Amended protocol allowed patients with PI  <textline bbox="91.224,267.190,572.972,291.190" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8211; Amended protocol allowed patients with PI  </textline>
</normal_text>
<normal_text id="7" bbox="91.224,175.010,622.412,199.010" size="24.0" unique_id="7">&#8211; Escape clause @ week 8 to allow subjects with  <textline bbox="91.224,175.010,622.412,199.010" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8211; Escape clause @ week 8 to allow subjects with  </textline>
</normal_text>
<normal_text id="8" bbox="113.780,117.372,424.796,170.210" size="22.02" unique_id="8">VF to receive TPV in 1182.17 
&#8226; Loss of control arm @ week 8 <textline bbox="113.780,146.210,424.796,170.210" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">VF to receive TPV in 1182.17 </textline>
<textline bbox="127.220,117.372,409.447,137.412" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8226; Loss of control arm @ week 8 </textline>
</normal_text>
<normal_text id="5" bbox="113.780,238.385,588.733,262.409" size="24.024" unique_id="5">resistant virus to receive a PI-based regimen <textline bbox="113.780,238.385,588.733,262.409" font="ArialMT" ncolour="1" size="24.024" colourspace="Pattern">resistant virus to receive a PI-based regimen </textline>
</normal_text>
</normal_text><normal_text bbox="127.22,209.562,404.878,321.782" unique_id="['3', '6']">&#8226; TPV/r + OBR vs CPI/r + OBR &#8226; Analyzed as superiority trials <normal_text id="3" bbox="127.220,301.742,404.878,321.782" size="20.04" unique_id="3">&#8226; TPV/r + OBR vs CPI/r + OBR <textline bbox="127.220,301.742,404.878,321.782" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8226; TPV/r + OBR vs CPI/r + OBR </textline>
</normal_text>
<normal_text id="6" bbox="127.220,209.562,399.708,229.602" size="20.04" unique_id="6">&#8226; Analyzed as superiority trials <textline bbox="127.220,209.562,399.708,229.602" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8226; Analyzed as superiority trials </textline>
</normal_text>
</normal_text></enlisting></page>
<page id="8" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[103.76764285714285, 442.9984642857143, 624.8131785714286, 489.46675]">
<title id="0" bbox="62.592,450.078,657.317,490.038" size="39.96" unique_id="0">Tipranavir/r: Patient Population <textline bbox="62.592,450.078,657.317,490.038" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="39.960" colourspace="Pattern">Tipranavir/r: Patient Population </textline>
</title>
<enlisting id="5" bbox="127.220,90.984,615.428,178.370" size="24.008" unique_id="5">&#8226; 97% of isolates resistant to at least 1 PI 
&#8226; 95% of isolates resistant to at least 1 NRTI 
&#8226; 75% of isolates resistant to at least 1 NNRTI <textline bbox="127.220,154.370,565.412,178.370" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; 97% of isolates resistant to at least 1 PI </textline>
<textline bbox="127.220,122.685,598.217,146.709" font="ArialMT" ncolour="1" size="24.024" colourspace="Pattern">&#8226; 95% of isolates resistant to at least 1 NRTI </textline>
<textline bbox="127.220,90.984,615.428,114.984" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; 75% of isolates resistant to at least 1 NNRTI </textline>
</enlisting>
<slide_number id="6" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="6">8 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">8 </textline>
</slide_number>
<enlisting bbox="55.2,186.178,612.475,396.471" unique_id="['1', ' 2', ' 4', '3']">&#8226; Highly treatment experienced &#8211; 3 class experienced 
&#8211; Median number of 12 prior antiretroviral  &#8211; Prior T-20 use in 12% 
&#8211; Baseline resistance  <normal_text id="1" bbox="55.200,364.407,498.190,396.471" size="32.064" unique_id="1">&#8226; Highly treatment experienced <textline bbox="55.200,364.407,498.190,396.471" font="ArialMT" ncolour="1" size="32.064" colourspace="Pattern">&#8226; Highly treatment experienced </textline>
</normal_text>
<normal_text id="2" bbox="91.224,290.358,612.475,355.278" size="27.96" unique_id="2">&#8211; 3 class experienced 
&#8211; Median number of 12 prior antiretroviral  <textline bbox="91.224,327.318,361.394,355.278" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; 3 class experienced </textline>
<textline bbox="91.224,290.358,612.475,318.318" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Median number of 12 prior antiretroviral  </textline>
</normal_text>
<normal_text id="4" bbox="91.224,186.178,382.788,251.098" size="27.96" unique_id="4">&#8211; Prior T-20 use in 12% 
&#8211; Baseline resistance  <textline bbox="91.224,223.138,382.788,251.098" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Prior T-20 use in 12% </textline>
<textline bbox="91.224,186.178,364.581,214.138" font="ArialMT" ncolour="1" size="27.960" colourspace="Pattern">&#8211; Baseline resistance  </textline>
</normal_text>
<normal_text id="3" bbox="113.780,260.113,191.752,288.097" size="27.984" unique_id="3">drugs  <textline bbox="113.780,260.113,191.752,288.097" font="ArialMT" ncolour="1" size="27.984" colourspace="Pattern">drugs  </textline>
</normal_text>
</enlisting></page>
<page id="9" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[96.53749999999998, 444.57169444444446, 630.1466944444444, 489.59369444444445]">
<title id="0" bbox="71.232,450.078,648.814,490.038" size="39.96" unique_id="0">Tipranavir/r: FDA Presentation <textline bbox="71.232,450.078,648.814,490.038" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="39.960" colourspace="Pattern">Tipranavir/r: FDA Presentation </textline>
</title>
<slide_number id="4" bbox="669.000,28.036,676.806,42.076" size="14.04" unique_id="4">9 <textline bbox="669.000,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">9 </textline>
</slide_number>
<enlisting bbox="55.2,82.344,343.97,396.839" unique_id="['1', '2', '3']">&#8226; Efficacy evaluation  
&#8226; Resistance evaluation 
&#8226; Exposure-response data 
&#8226; Drug-drug interactions &#8211; CYP 3A inhibitor 
&#8211; PgP inducer 
&#8226; Safety profile 
&#8211; Hepatoxicity  
&#8211; Rash 
&#8211; Hyperlipidemia &#8226; Summary <normal_text id="1" bbox="55.200,277.750,343.970,396.839" size="24.006" unique_id="1">&#8226; Efficacy evaluation  
&#8226; Resistance evaluation 
&#8226; Exposure-response data 
&#8226; Drug-drug interactions <textline bbox="55.200,372.815,288.326,396.839" font="ArialMT" ncolour="1" size="24.024" colourspace="Pattern">&#8226; Efficacy evaluation  </textline>
<textline bbox="55.200,341.110,316.944,365.110" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; Resistance evaluation </textline>
<textline bbox="55.200,309.430,343.970,333.430" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; Exposure-response data </textline>
<textline bbox="55.200,277.750,319.724,301.750" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; Drug-drug interactions </textline>
</normal_text>
<normal_text id="2" bbox="55.200,114.012,259.144,271.401" size="20.703999999999997" unique_id="2">&#8211; CYP 3A inhibitor 
&#8211; PgP inducer 
&#8226; Safety profile 
&#8211; Hepatoxicity  
&#8211; Rash 
&#8211; Hyperlipidemia <textline bbox="91.224,251.337,259.144,271.401" font="ArialMT" ncolour="1" size="20.064" colourspace="Pattern">&#8211; CYP 3A inhibitor </textline>
<textline bbox="91.224,224.922,222.557,244.962" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8211; PgP inducer </textline>
<textline bbox="55.200,193.250,222.192,217.250" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; Safety profile </textline>
<textline bbox="91.224,166.842,228.469,186.882" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8211; Hepatoxicity  </textline>
<textline bbox="91.224,140.442,160.593,160.482" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8211; Rash </textline>
<textline bbox="91.224,114.012,246.345,134.052" font="ArialMT" ncolour="1" size="20.040" colourspace="Pattern">&#8211; Hyperlipidemia </textline>
</normal_text>
<normal_text id="3" bbox="55.200,82.344,184.896,106.344" size="24.0" unique_id="3">&#8226; Summary <textline bbox="55.200,82.344,184.896,106.344" font="ArialMT" ncolour="1" size="24.000" colourspace="Pattern">&#8226; Summary </textline>
</normal_text>
</enlisting></page>
<page id="10" bbox="0.000,0.000,720.000,540.000" rotate="0" mean_title="[96.13239999999999, 445.18975555555556, 629.2269555555556, 490.0153555555555]">
<title id="0" bbox="94.512,447.662,625.548,491.702" size="44.04" unique_id="0">NDA 21-814 Review Team <textline bbox="94.512,447.662,625.548,491.702" font="Arial-BoldMT" ncolour="(1, 1, 0)" size="44.040" colourspace="Pattern">NDA 21-814 Review Team </textline>
</title>
<normal_text id="1" bbox="87.264,297.370,286.920,423.400" size="18.004" unique_id="1">Clinical 
Jeff Murray 
Rosemary Johann-Liang 
Andrea James 
Melisse Baylor 
Neville Gibbs <textline bbox="87.264,405.400,151.290,423.400" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Clinical </textline>
<textline bbox="91.224,383.800,180.846,401.800" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Jeff Murray </textline>
<textline bbox="91.224,362.195,286.920,380.219" font="ArialMT" ncolour="1" size="18.024" colourspace="Pattern">Rosemary Johann-Liang </textline>
<textline bbox="91.224,340.570,207.126,358.570" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Andrea James </textline>
<textline bbox="91.224,318.970,207.846,336.970" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Melisse Baylor </textline>
<textline bbox="91.224,297.370,197.154,315.370" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Neville Gibbs </textline>
</normal_text>
<normal_text id="2" bbox="91.224,189.350,195.156,272.170" size="18.0" unique_id="2">Virology 
Jules O&#8217;Rear 
Lisa Naeger 
Kim Struble <textline bbox="91.224,254.170,163.008,272.170" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Virology </textline>
<textline bbox="91.224,232.550,195.156,250.550" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Jules O&#8217;Rear </textline>
<textline bbox="91.224,210.950,188.082,228.950" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Lisa Naeger </textline>
<textline bbox="91.224,189.350,184.194,207.350" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Kim Struble </textline>
</normal_text>
<normal_text id="3" bbox="91.224,102.920,206.073,164.150" size="18.008" unique_id="3">Chemistry 
Stephen Miller 
Ko Yu-lo <textline bbox="91.224,146.150,179.154,164.150" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Chemistry </textline>
<textline bbox="91.224,124.545,206.073,142.569" font="ArialMT" ncolour="1" size="18.024" colourspace="Pattern">Stephen Miller </textline>
<textline bbox="91.224,102.920,158.828,120.920" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Ko Yu-lo </textline>
</normal_text>
<normal_text id="4" bbox="91.224,16.524,267.138,56.124" size="18.0" unique_id="4">Project Management 
Tanima Sinha <textline bbox="91.224,38.124,267.138,56.124" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Project Management </textline>
<textline bbox="91.224,16.524,200.178,34.524" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Tanima Sinha </textline>
</normal_text>
<normal_text id="5" bbox="487.300,340.570,584.302,423.400" size="18.006" unique_id="5">Statistical 
Greg Soon 
Rafia Bhore 
Susan Zhou <textline bbox="487.300,405.400,572.278,423.400" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Statistical </textline>
<textline bbox="487.300,383.800,574.222,401.800" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Greg Soon </textline>
<textline bbox="487.300,362.195,582.268,380.219" font="ArialMT" ncolour="1" size="18.024" colourspace="Pattern">Rafia Bhore </textline>
<textline bbox="487.300,340.570,584.302,358.570" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Susan Zhou </textline>
</normal_text>
<normal_text id="6" bbox="487.300,210.950,605.110,272.170" size="18.0" unique_id="6">Toxicology 
James Farrelly 
Anita Bigger <textline bbox="487.300,254.170,581.152,272.170" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Toxicology </textline>
<textline bbox="487.300,232.550,605.110,250.550" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">James Farrelly </textline>
<textline bbox="487.300,210.950,585.148,228.950" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Anita Bigger </textline>
</normal_text>
<normal_text id="7" bbox="487.300,59.724,655.294,164.150" size="18.0048" unique_id="7">Clin. Pharmacology 
Kellie Reynolds 
Derek Zhang 
Jenny J. Zheng 
Joga Gobburu <textline bbox="487.300,146.150,655.294,164.150" font="Arial-BoldMT" ncolour="1" size="18.000" colourspace="Pattern">Clin. Pharmacology </textline>
<textline bbox="487.300,124.545,610.764,142.569" font="ArialMT" ncolour="1" size="18.024" colourspace="Pattern">Kellie Reynolds </textline>
<textline bbox="487.300,102.920,591.286,120.920" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Derek Zhang </textline>
<textline bbox="487.300,81.324,610.222,99.324" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Jenny J. Zheng </textline>
<textline bbox="487.300,59.724,601.222,77.724" font="ArialMT" ncolour="1" size="18.000" colourspace="Pattern">Joga Gobburu </textline>
</normal_text>
<slide_number id="8" bbox="661.200,28.036,676.806,42.076" size="14.04" unique_id="8">10 <textline bbox="661.200,28.036,676.806,42.076" font="ArialMT" ncolour="0" size="14.040" colourspace="Pattern">10 </textline>
</slide_number>
</page>
</pages>